onx_logo

On-X Life Technologies, Inc. (On-X LTI) is committed to restoring the patient’s quality of life by developing, manufacturing and marketing products that are unsurpassed in quality and performance.

On-X LTI, a privately held company, was founded in 1994 and is located in Austin, Texas.

The primary focus of On-X LTI is threefold:

  • Continually improve pyrolytic carbon coating technology along with supporting processing and inspection technologies,
  • Advance the level of prosthetic heart valve performance while reducing the level of patient valve related complications, and
  • Provide additional cardiac surgery products that uniquely improve patient care.

The On-X LTI story is unique among medical device companies because On-X LTI’s management and production teams have been at the forefront of the tandem technologies of carbon biomaterials and prosthetic heart valve design since the 1960’s. Our state-of-the-art On-X valve is attracting worldwide attention for its outstanding clinical performance.

On-X LTI also collaborates with a number of companies to develop and manufacture components for their products utilizing our proprietary and leading edge pyrolytic carbon processing technologies.

 

www.onxlti.com

On-X heart valves

Heart Valves On-X

On-X Life Technologies, Inc. (On-X LTI) is committed to restoring the patient’s quality of life by developing, manufacturing and marketing products that are unsurpassed in quality and performance.

On-X mechanical heart valves are made from carbon. On-X carbon differs from the carbon used in other valves in that it is not alloyed with silicon carbide. It is 100% pure carbon. The silicon alloying in other valves is a means of providing consistent wear resistance required by heart valves.

Every aspect of the On-X valve plays a role in maximizing benefits for the recipient. The scope of innovations in the design reflects the MCRI’s commitment to perfection in creating the On-X Prosthetic Heart Valve.

 

Design Features

Implantation video

FDA Clinical Results

Low Anticoagulation Study

 

onx